Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo Dienstmann

Showing results (131-140 of 176) with videos related to

Pageof 18
Sort By:
JCO Global Oncology|January 23, 2025
Precision Oncology: A Global Perspective on Implementation and Policy DevelopmentDenis Horgan, Marcel Tanner, Charu Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
High <i>FGFR1-4</i> mRNA Expression Levels Correlate with Response to Selective FGFR Inhibitors in Breast CancerMònica Sánchez-Guixé, Cinta Hierro, José Jiménez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2015
MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal CancerCelina García-García, Martín A Rivas, Yasir H Ibrahim, et al.
JCO Global Oncology|November 21, 2024
Real-World Study on Implementation of Genomic Tests for Advanced Lung Adenocarcinoma in BrazilRodrigo Dienstmann, Leonard M da Silva, Fernanda Orpinelli Ramos do Rego, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2019
Capturing Hyperprogressive Disease with Immune-Checkpoint Inhibitors Using RECIST 1.1 CriteriaIgnacio Matos, Juan Martin-Liberal, Alonso García-Ruiz, et al.
JCO Global Oncology|November 9, 2022
Impact of the COVID-19 Pandemic on Cancer Staging: An Analysis of Patients With Breast Cancer From a Community Practice in BrazilCristiano A A Resende, Heloísa M Fernandes Cruz, Matheus Costa E Silva, et al.
European Journal of Radiology|July 1, 2026
Co-clinical CT radiomics pipeline to establish candidate imaging biomarkers for colorectal cancerKate Connor, Olivia Prior, Liam P Shiels, et al.
International Journal of Molecular Sciences|January 8, 2023
A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with ImmunotherapyElena Élez, Núria Mulet-Margalef, Miriam Sanso, et al.
Cell Reports|August 31, 2017
Genomic Determinants of Protein Abundance Variation in Colorectal Cancer CellsTheodoros I Roumeliotis, Steven P Williams, Emanuel Gonçalves, et al.
Nature Medicine|July 8, 2020
Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board PortalDavid Tamborero, Rodrigo Dienstmann, Maan Haj Rachid, et al.
Pageof 18

Showing results (131-140 of 176) with videos related to

Sort By:
Pageof 18
JCO Global Oncology|January 23, 2025
Precision Oncology: A Global Perspective on Implementation and Policy DevelopmentDenis Horgan, Marcel Tanner, Charu Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
High <i>FGFR1-4</i> mRNA Expression Levels Correlate with Response to Selective FGFR Inhibitors in Breast CancerMònica Sánchez-Guixé, Cinta Hierro, José Jiménez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2015
MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal CancerCelina García-García, Martín A Rivas, Yasir H Ibrahim, et al.
JCO Global Oncology|November 21, 2024
Real-World Study on Implementation of Genomic Tests for Advanced Lung Adenocarcinoma in BrazilRodrigo Dienstmann, Leonard M da Silva, Fernanda Orpinelli Ramos do Rego, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2019
Capturing Hyperprogressive Disease with Immune-Checkpoint Inhibitors Using RECIST 1.1 CriteriaIgnacio Matos, Juan Martin-Liberal, Alonso García-Ruiz, et al.
JCO Global Oncology|November 9, 2022
Impact of the COVID-19 Pandemic on Cancer Staging: An Analysis of Patients With Breast Cancer From a Community Practice in BrazilCristiano A A Resende, Heloísa M Fernandes Cruz, Matheus Costa E Silva, et al.
European Journal of Radiology|July 1, 2026
Co-clinical CT radiomics pipeline to establish candidate imaging biomarkers for colorectal cancerKate Connor, Olivia Prior, Liam P Shiels, et al.
International Journal of Molecular Sciences|January 8, 2023
A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with ImmunotherapyElena Élez, Núria Mulet-Margalef, Miriam Sanso, et al.
Cell Reports|August 31, 2017
Genomic Determinants of Protein Abundance Variation in Colorectal Cancer CellsTheodoros I Roumeliotis, Steven P Williams, Emanuel Gonçalves, et al.
Nature Medicine|July 8, 2020
Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board PortalDavid Tamborero, Rodrigo Dienstmann, Maan Haj Rachid, et al.
Pageof 18